Skip to main content
. 2019 Jan;11(1):68–83. doi: 10.21037/jtd.2018.12.20

Table 1. Demographic and characteristics of the enrolled patients according to inhospital mortality and ECMO weaning.

Characteristics Survivor vs. non-survivor Weaning vs. failed weaning Total (N=135)
Survivor (N=35) Non-survivor (N=100) P Weaning (N=53) Failed weaning (N=82) P
Age (years) 51.91±17.64 62.08±15.40 0.002 55.43±18.67 62.04±14.57 0.032 59.44±16.56
Age subgroup 0.006 0.096
   <50 15 (42.86) 16 (16.00) 18 (33.96) 13 (15.85) 31 (22.96)
   ≥50 and <60 6 (17.14) 21 (21.00) 10 (18.87) 17 (20.73) 27 (20.00)
   ≥60 and <70 8 (22.86) 23 (23.00) 11 (20.75) 20 (24.39) 31 (22.96)
   ≥70 6 (17.14) 40 (40.00) 14 (26.42) 32 (39.02) 46 (34.07)
Sex (male/female) 27/8 67/33 0.363 38/15 56/26 0.819 94/41
Height (cm) 166.69±7.61 163.21±8.96 0.042 165.02±7.99 163.52±9.18 0.330 164.11±8.73
Body weight (kg) 68.63±11.41 65.70±10.90 0.179 67.75±10.88 65.63±11.17 0.277 66.46±11.07
Body mass index (kg/m2) 24.70±3.93 24.59±3.16 0.870 24.85±3.52 24.47±3.27 0.515 24.62±3.36
Body mass index subgroup 0.381 0.902
   Normal (18.5–22.9) 15 (42.86) 35 (35.00) 18 (33.96) 32 (39.02) 50 (37.04)
   Overweight (23.0–24.9) 7 (20.00) 27 (27.00) 14 (26.42) 20 (24.39) 34 (25.19)
   Obese (25.0–29.9) 10 (28.57) 35 (35.00) 18 (33.96) 27 (32.93) 45 (33.33)
   Highly obese (≥30) 3 (8.57) 3 (3.00) 3 (5.66) 3 (3.66) 6 (4.44)
ECMO type (VA/VV-VA/VA-VV/VAV/VA-VAV) 32/2/0/1/0 97/1/1/0/1 0.182 50/2/0/1/0 79/1/1/0/1 0.434 129/3/1/1/1
Anticoagulation (heparin/nafamostat/no) 14/21/0 41/53/6 0.311 23/30/0 32/44/6 0.130 55/74/6
Primary origin (Ca/Re/Se/Tr) 25/1/8/1 80/0/19/1 0.273 42/1/9/1 63/0/18/1 0.559 105/1/27/2
Admission route (ER/GW) 24/11 60/40 0.485 36/17 48/34 0.359 84/52
Arrest occurrence 16 (45.71) 85 (85.00) <0.001 31 (58.49) 70 (85.37) <0.001 101 (74.81)
Arrest place (out-hospital/in-hospital/no) 19/10/6 15/24/61 <0.001 22/13/18 12/21/49 <0.001 34/334/67
CPR performance 17 (48.57) 85 (85.00) 0.04 32 (60.38) 70 (85.37) 0.002 102 (75.56)
CPR time (min) 34.41±21.15 58.75±41.18 0.021 45.50±42.00 58.90±37.95 0.114 54.69±39.55
ECPR 12 (34.29) 75 (75.00) <0.001 26 (49.06) 61 (74.39) 0.01 87 (64.44)
Operation (no/after OP/with/after ECMO) 30/2/0/3 92/2/2/4 0.382 47/2/0/4 75/2/2/3 0.484 122/4/2/7
ECMO pump type 0.815 0.176
Cause of death 0.00±0.00 6.39±4.50 <0.001 1.66±3.51 6.72±4.44 <0.001 4.73±4.78
Survival and weaning <0.001 <0.001
   Survival after successful weaning 35 (100.00) 0 (0.0) 35 (66.04) 0 (0.0) 35 (25.93)
   Successful weaning,.but expired 0 (0.0) 18 (18.00) 18 (33.96) 0 (0.0) 82 (60.74)
   Failed weaning and expired 0 (0.0) 82 (82.00) 0 (0.0) 82 (100.00) 18 (13.33)
Weaning (success/fail) 35/0 18/82 <0.001 53/0 0/82 <0.001 53/82
HD stay (days) 43.37±28.25 7.75±9.42 <0.001 33.43±27.41 6.35±8.71 <0.001 16.99±22.66
ICU stay (days) 24.06±18.60 6.92±7.62 <0.001 20.60±16.88 5.39±5.95 <0.001 11.36±13.70
ECMO time (hours) 124.09±76.69 91.02±110.09 0.055 128.13±82.21 81.15±111.43 0.006 99.59±103.24
CRRT 23 (65.71) 74 (74.00) 0.472 36 (67.92) 61 (74.39) 0.535 97 (71.85)
IABP 4 (11.43) 18 (18.00) 0.041 6 (11.32) 16 (19.51) 0.106 22 (16.30)
ARF 9 (25.71) 55 (55.00) 0.005 22 (41.51) 42 (51.22) 0.354 64 (47.41)
DM 8 (22.86) 43 (43.00) 0.056 15 (28.30) 36 (43.90) 0.100 51 (37.78)
Hypertension 11 (31.43) 45 (45.00) 0.229 17 (32.08) 39 (47.56) 0.109 56 (41.48)
SAPS II 67.77±20.79 90.29±13.31 <0.001 74.91±20.81 90.62±13.56 <0.001 84.45±18.40
   SAPS II (60/cutoff) 11/24 2/98 <0.001 11/42 2/80 <0.001 13/122
   SAPS II (70/cutoff) 15/20 8/92 <0.001 16/37 7/75 0.002 23/112
   SAPS II (80/cutoff) 22/13 17/83 <0.001 26/27 13/69 <0.001 39/96
   SAPS II (90/cutoff) 32/3 43/57 <0.001 42/11 33/49 <0.001 75/60
   SAPS II (70/80/90/cutoff) 15/7/10/3 8/9/26/57 <0.001 16/10/16/11 7/6/20/49 <0.001 23/16/36/60
SOFA 12.63±3.49 15.33±2.28 <0.001 13.64±3.35 15.27±2.36 0.001 14.63±2.89
PDR 71.12±30.51 94.00±9.36 <0.001 78.96±27.29 93.95±9.90 <0.001 88.07±20.06
iCK-MB 24.25±75.01 52.66±122.76 0.205 24.94±66.54 58.46±133.23 0.092 45.30±112.77
iTroponin 7.21±21.03 15.79±54.36 0.374 5.99±17.63 18.56±59.85 0.145 13.51±47.90
iBUN 20.96±21.27 25.56±19.61 0.247 22.48±19.59 25.58±20.41 0.386 24.36±20.07
iCr 1.99±3.64 1.86±1.58 0.786 1.94±3.00 1.87±1.68 0.861 1.90±2.28
ipH 7.14±0.22 6.98±0.15 <0.001 7.12±0.20 6.98±0.15 <0.001 7.02±0.19
Lactate 7.09±4.93 12.11±4.84 <0.001 7.37±4.65 12.44±4.86 <0.001 10.70±5.33
BNP 525.29±1164.03 798.35±1090.82 0.199 816.68±1462.18 646.40±838.05 0.488 712.12±1111.37
pCK-MB 175.80±256.60 197.36±246.01 0.391 212.74±279.29 178.21±226.29 0.457 191.77±248.01
pTroponin 50.03±94.51 77.65±122.23 0.227 68.32±102.38 71.89±124.57 0.862 70.49±115.98
pBUN 34.84±20.46 38.56±36.49 0.460 43.59±29.84 33.72±34.60 0.090 37.60±33.05
pCr 2.15±2.17 2.17±1.68 0.042 2.33±1.97 2.06±1.70 0.090 2.17±1.81
pTB 4.61±5.78 4.81±8.14 0.879 6.29±7.34 3.77±7.61 0.059 4.76±7.58
ipH (<6.8, <7.0, <7.4, ≥7.4) 1/8/9/17 1/55/36/8 <0.001 2/11/21/19 0/52/24/6 <0.001 2/63/45/25

Continuous variables showing normality were expressed as the arithmetic mean ± standard deviation, and categorical variables were displayed as frequency distributions (percentage). ECMO, extracorporeal membrane oxygenation; AMI, acute myocardial infarction; ER, emergency room; VA, venoarterial; VV, venovenous, VAV, venoarterial venous; Ca, cardiac origin; Re, respiratory origin; Se, sepsis origin; Tr, trauma origin; GW, general ward; CPR, cardiopulmonary resuscitation; ECPR, extracorporeal cardiopulmonary resuscitation; OP, operation; HD, hospitalization day; ICU, intensive care unit; CRRT, continuous renal replacement therapy; IABP, intraaortic balloon pump; ARF, acute renal failure; DM, diabetes mellitus; SAPS II, simplified acute physiology Score II; SOFA, sepsis-related organ failure assessment; PDR, predicted death rate; BUN, blood urea nitrogen; Cr, creatinine; CK-MB, creatine kinase MB isoenzyme; TB, total bilirubin; BNP, brain natriuretic peptide.